DIAGNOS Inc. announced a non-brokered private placement of 10% unsecured convertible debentures and stock warrants for gross proceeds of CAD 865,000 on May 18, 2023. The Debentures have a term of 24 months ending May 18, 2025 and bear interest at the annual rate of 10%. At the option of the Debenture holder, the principal amount of the Debenture may be converted, at any time during the Term, into common shares of the Corporation at a price of CAD 0.37 per Share. Any accrued interest on the principal, at time of conversion, will be immediately payable in cash. An aggregate number of 865,000 Warrants have been issued as part of the Private Placement. Each Warrant entitles the holder to purchase one Share at a price of CAD 0.45 per Share, for a period of 18 months ending November 18, 2024. In connection with the closing of the transaction, the Corporation will pay a cash commission of CAD 15,500 to one qualified firm acting at arm's length, Optimista Consulting Services Inc. All securities issued as part of the transaction are subject to a statutory hold period ending September 19, 2023. The transaction remains subject to receipt of all required approvals, including the approval of the TSX Venture Exchange, as well as execution of formal documentation.

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement. The transaction included participation from eight placees including pro-group involvement of one pro group for 40,540.